The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Case Report
One year follow-up and literature review of three young-age cases with high risk pulmonary thromboembolism
High-risk pulmonary thromboembolism (PTE) is an emergency clinical condition with high mortality. High-risk pulmonary thromboembolism is generally seen in immobile patients, elderly, have malignancies, and have a long-term travel history. Our aim here is to emphasize that high-risk pulmonary thromboembolism may also occur in young patients. Considering the symptoms and risk factors such as oral contraceptive use, obesity, and operation history, PTE can be detected with Pulmonary Computed Tomography-Angiography (CTPA) or Ventilation Perfusion Scintigraphy (V/Q) when necessary. It should be verified that it is not. Genetic mutation, obesity, oral contraceptive use, and previous operation history were accepted as risk factors in the young patients we treated and followed up with high-risk Pulmonary Thromboembolism presented here. After the diagnosis of pulmonary thromboembolism was made at the first stage in our patients who applied to the emergency department, the risk group was determined by taking into account the current guidelines. Three patients considered to be at high risk were evaluated for thrombolytic therapy. Two patients without contraindications were given a full dose, and one patient was given a half dose of thrombolytic. After being monitored in intensive care for the first 24 hours, they were taken to the service. Due to their young age (<45 years), their thrombophilia panel was checked. Anticoagulant treatments were started and follow-ups were planned at 3 months, 6 months, and 1 year after discharge. During the follow-up visits, CTPA, echocardiography (ECHO), and lower extremity Doppler ultrasound imaging were performed.

1. Turkish Thoracic Society. Pulmonary thromboembolism diagnosis and treatment consensus report 2021.
2. G&ouml;lbaşi Z. Kronik tromboembolik pulmoner hipertansiyon: Tanisi, tibbi tedavisi ve takibi [Chronic thromboembolic pulmonary hypertension: diagnosis, medical therapy and monitoring].Anadolu Kardiyol Derg. 2010;10 Suppl 2:56-60.
3. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respir atory Society (ERS) The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).Eur Heart J.2020;41(4):543-603.
4. Şen N, Ermiş H, Altınkaya N, Ermiş N, Karataşlı M, Ulubay G. Pulmonary embolism in young and elderly patients: clinical characteristics, laboratory and instrumental findings and differences between age groups. <em>Thorac Res Pract</em>. 2010;11:160-166. Doi: 10.5152/ttd.2010.26
5. Ol&ccedil;um GG, Akbaş S, Basat S. 27 Patients with pulmonary thromboembolism.Med Bull Sisli Etfal Hosp.2015;49(4):260-265.
6. İpekci A. Pulmonary embolism 2019. Phnx Med J. 2019;1(1):51-63.
7. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism.Circulation. 2003;107(23 Suppl 1):I9-I16.
Volume 2, Issue 2, 2024
Page : 42-45